Clinical trials
Tuberculosis, Pulmonary trials in Pakistan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 2 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dow University of Health Sciences | 2 |
| Médecins Sans Frontières, France | 2 |
| Aga Khan University | 1 |
| Allama Iqbal Open University Islamabad | 1 |
| Faisal Faiyaz Zuberi | 1 |
| Farman Ullah Khan | 1 |
| Khyber Medical University Peshawar | 1 |
| St George's, University of London | 1 |
| University of California, San Francisco | 1 |
| Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 12 |
| Tuberculosis | 4 |
| Tuberculosis, Multidrug-Resistant | 3 |
| Bacterial Infections | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Digestive System Diseases | 1 |
| Extensively Drug-Resistant Tuberculosis | 1 |
| Gram-Positive Bacterial Infections | 1 |
| Inflammation | 1 |
| Mycobacterium Infections | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.